Xi Lu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Xi Lu has a total of 9 co-authors. Here are the top co-authors by number of shared publications:
- Chuqiao Jiao
Beijing City International School, Beijing 100022, China
1 shared publication - Dong Han
CAS Center for Excellence in Nanoscience
1 shared publication - Huizhen Sun
College of Life Sciences, Bejing University of Chinese Medicine, Beijing 100029, China
1 shared publication - Kai Li
College of Life Sciences, Bejing University of Chinese Medicine, Beijing 100029, China
1 shared publication - Tingting Li
College of Life Sciences, Bejing University of Chinese Medicine, Beijing 100029, China
1 shared publication - Tun Yan
College of Life Sciences, Bejing University of Chinese Medicine, Beijing 100029, China
1 shared publication
Latest Publications
- Open Access
- 20 July 2022
- Published by MDPI AG in Pharmaceuticals
- Vol. 15 (7) , 896
Phloridzin Reveals New Treatment Strategies for Liver Fibrosis
Liver fibrosis is an urgent public health problem which is difficult to resolve. However, various drugs for the treatment of liver fibrosis in clinical practice have their own problems during use. In this study, we used phloridzin to treat hepatic fibrosis in the CCl4-induced C57/BL6N mouse model, which was extracted from lychee core, a traditional Chinese medicine. The therapeutic effect was evaluated by biochemical index detections and ultrasound detection. Furthermore, in order to determine the mechanism of phloridzin in the treatment of liver fibrosis, we performed high-throughput sequencing of mRNA and lncRNA in different groups of liver tissues. The results showed that compared with the model group, the phloridzin-treated groups revealed a significant decrease in collagen deposition and decreased levels of serum alanine aminotransferase, aspartate aminotransferase, laminin, and hyaluronic acid. GO and KEGG pathway enrichment analysis of the differential mRNAs was performed and revealed that phloridzin mainly affects cell ferroptosis. Gene co-expression analysis showed that the target genes of lncRNA were obvious in cell components such as focal adhesions, intercellular adhesion, and cell–substrate junctions and in metabolic pathways such as carbon metabolism. These results showed that phloridizin can effectively treat liver fibrosis, and the mechanism may involve ferroptosis, carbon metabolism, and related changes in biomechanics.
- 20 July 2022
- Published by MDPI AG in Pharmaceuticals
- Vol. 15 (7) , 896
Open AccessPhloridzin Reveals New Treatment Strategies for Liver Fibrosis
Liver fibrosis is an urgent public health problem which is difficult to resolve. However, various drugs for the treatment of liver fibrosis in clinical practice have their own problems during use. In this study, we used phloridzin to treat hepatic fibrosis in the CCl4-induced C57/BL6N mouse model, which was extracted from lychee core, a traditional Chinese medicine. The therapeutic effect was evaluated by biochemical index detections and ultrasound detection. Furthermore, in order to determine the mechanism of phloridzin in the treatment of liver fibrosis, we performed high-throughput sequencing of mRNA and lncRNA in different groups of liver tissues. The results showed that compared with the model group, the phloridzin-treated groups revealed a significant decrease in collagen deposition and decreased levels of serum alanine aminotransferase, aspartate aminotransferase, laminin, and hyaluronic acid. GO and KEGG pathway enrichment analysis of the differential mRNAs was performed and revealed that phloridzin mainly affects cell ferroptosis. Gene co-expression analysis showed that the target genes of lncRNA were obvious in cell components such as focal adhesions, intercellular adhesion, and cell–substrate junctions and in metabolic pathways such as carbon metabolism. These results showed that phloridizin can effectively treat liver fibrosis, and the mechanism may involve ferroptosis, carbon metabolism, and related changes in biomechanics.